Skip to main content
. 2020 Apr 14;11(2):e00603-20. doi: 10.1128/mBio.00603-20

TABLE 2.

MIC assessments with β-lactamase inhibitor combinations

Drug MIC (μg/ml)
AJ218 plus empty vector
AJ218 ΔK35 ΔK36 plus empty vector
No inhibitor Tazobactama Avibactamb No inhibitor Tazobactama Avibactamb
Ampicillin 8,192 4 4 8,192 1,024 32
Cefazolin 8 0.5 1 1,024 256 16
Ceftazidime 0.5 0.125 0.25 4 1 1
Ceftriaxone 0.0625 0.03125 0.0625 0.5 0.5 0.5
Cefotaxime 0.0625 0.03125 0.0625 0.5 0.5 0.5
Imipenem 0.5 0.25 0.25 0.5 0.25 0.5
Meropenem 0.03125 0.015625 0.03125 0.5 0.5 0.0625
Ertapenem 0.015625 0.008 0.015625 4 2 1
a

Tazobactam was used at a final concentration of 64 μg/ml.

b

Avibactam was used at a final concentration of 4 μg/ml.